SS
TCRT icon

Simplicity Solutions’s Alaunos Therapeutics TCRT Stock Holding History

Simplicity Solutions’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.01K Hold
95
– – ﹤0.01% 1070
2023
Q3 		$1.88K Sell
95
-2
-2% -$86 ﹤0.01% 993
2023
Q2 		$7.41K Buy
97
+6
+7% +$485 ﹤0.01% 1057
2023
Q1 		$8.56K Buy
+91
New +$8.66K ﹤0.01% 1163

Other funds holding TCRT

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $583M AUM 25.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Simplicity Solutions's TCRT Position: Q4 2023 in Review

Simplicity Solutions held its Alaunos Therapeutics (TCRT) position steady in Q4 2023 at 95 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Simplicity Solutions first reported a position in TCRT in Q1 2023 and has held it in 4 quarters since. The position peaked at $8.56K in Q1 2023. 83 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • Simplicity Solutions held 95 shares of Alaunos Therapeutics worth $1.01K as of Q4 2023.
  • Simplicity Solutions left its Alaunos Therapeutics share count unchanged in Q4 2023.
  • Alaunos Therapeutics made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1070 holding.
  • Simplicity Solutions first reported a position in Alaunos Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Simplicity Solutions's Alaunos Therapeutics position peaked at $8.56K in Q1 2023.
  • 83 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.